{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:11:17Z","timestamp":1784157077137,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.medcli.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T11:05:52Z","timestamp":1713524752000},"page":"208.e1-208.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Documento de consenso de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), Sociedad Espa\u00f1ola de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atenci\u00f3n Primaria (SEMERGEN) y Asociaci\u00f3n Espa\u00f1ola de Migra\u00f1a y Cefalea (AEMICE) sobre el tratamiento de la migra\u00f1a"],"prefix":"10.1016","volume":"163","author":[{"given":"Robert","family":"Belv\u00eds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Irimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9sica","family":"Garc\u00eda-Ull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"L\u00f3pez-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Moroll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Quintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Gregorio","family":"Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tentor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gallego Artiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"P\u00e9rez Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Colomina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Lainez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.02.006_bib0435","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1157\/13101849","article-title":"Gu\u00eda de recomendaciones para el tratamiento de la migra\u00f1a en la pr\u00e1ctica cl\u00ednica","volume":"207","author":"L\u00e1inez","year":"2007","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.medcli.2024.02.006_bib0440","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0445","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/0333102410382794","article-title":"One-year prevalence of migraine in Spain: A nationwide population-based survey","volume":"31","author":"Mat\u00edas-Guiu","year":"2011","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0450","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1474-4422(04)00703-3","article-title":"Lifting the burden: The global campaign against headache","volume":"3","author":"Steiner","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0455","unstructured":"Beltr\u00e1n J, L\u00f3pez A, Barrero C, Fern\u00e1ndez R, Garc\u00eda MG, Llundain A, et al., editores. Impacto y situaci\u00f3n de la Migra\u00f1a en Espa\u00f1a: Atlas 2018. Sevilla: Universidad de Sevilla; 2018. Disponible en: http:\/\/www.dolordecabeza.net\/wp-content\/uploads\/2018\/11\/3302.-Libro-AtlasMigra\u00f1a.pdf"},{"key":"10.1016\/j.medcli.2024.02.006_bib0460","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/ene.14431","article-title":"Estimating the savings associated with a migraine-free life: Results from the Spanish Atlas","volume":"27","author":"Irimia","year":"2020","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0470","doi-asserted-by":"crossref","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","article-title":"Analysis of shared heritability in common disorders of the brain","volume":"360","author":"Anttila","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.medcli.2024.02.006_bib0475","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","article-title":"Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles","volume":"54","author":"Hautakangas","year":"2022","journal-title":"Nat Genet."},{"key":"10.1016\/j.medcli.2024.02.006_bib0480","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0333102417690111","article-title":"Epigenetic DNA methylation changes associated with headache chronification: A retrospective case-control study","volume":"38","author":"Winsvold","year":"2018","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0485","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nat Med."},{"key":"10.1016\/j.medcli.2024.02.006_bib0490","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.2001.81.3.1065","article-title":"Mechanisms of spreading depression and hypoxic spreading depression-like depolarization","volume":"81","author":"Somjen","year":"2001","journal-title":"Physiol Rev."},{"key":"10.1016\/j.medcli.2024.02.006_bib0495","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","article-title":"Origin of pain in migraine: evidence for peripheral sensitisation","volume":"8","author":"Olesen","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0500","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","article-title":"Cutaneous allodynia in the migraine population","volume":"63","author":"Lipton","year":"2008","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0505","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev Physiol."},{"issue":"Pt 7","key":"10.1016\/j.medcli.2024.02.006_bib0510","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/brain\/aww097","article-title":"The migraine generator revisited: Continuous scanning of the migraine cycle over 30days and three spontaneous attacks","volume":"139","author":"Schulte","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0515","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrn3057","article-title":"Diencephalic and brainstem mechanisms in migraine","volume":"12","author":"Akerman","year":"2011","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.medcli.2024.02.006_bib0520","series-title":"Manual de pr\u00e1ctica cl\u00ednica en cefaleas. Recomendaciones diagn\u00f3stico-terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda 2020","author":"Santos-Lasaosa","year":"2020"},{"key":"10.1016\/j.medcli.2024.02.006_bib0525","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin."},{"key":"10.1016\/j.medcli.2024.02.006_bib0530","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","article-title":"Comorbidities of primary headache disorders: A literature review with meta-analysis","volume":"22","author":"Caponnetto","year":"2021","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0535","unstructured":"Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting The Burden. Ed. WHO Library Cataloguing-in-Publication Data. Trento, Italia, 2011."},{"key":"10.1016\/j.medcli.2024.02.006_bib0540","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nrl.2020.04.029","article-title":"Document of revision and updating of medication overuse headache (MOH)","volume":"36","author":"Gonz\u00e1lez-Oria","year":"2021","journal-title":"Neurologia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0550","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/039463201302600132","article-title":"Overuse of prescription and OTC non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis","volume":"26","author":"Cavagna","year":"2013","journal-title":"Int J Immunopathol Pharmacol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0555","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaip.2014.01.009","article-title":"Self-medication in persistent rhinitis: overuse of decongestants in half of the patients","volume":"2","author":"Mehuys","year":"2014","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.medcli.2024.02.006_bib0560","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaip.2015.06.021","article-title":"Albuterol overuse: A marker of psychological distress?","volume":"3","author":"Gerald","year":"2015","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.medcli.2024.02.006_bib0565","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0333102419828967","article-title":"Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition","volume":"39","author":"Diener","year":"2019","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0570","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1526-4610.2007.00868.x","article-title":"Predictors of migraine headache recurrence: A pooled analysis from the eletriptan database","volume":"48","author":"Dodick","year":"2008","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0575","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/head.12941","article-title":"Predicting inadequate response to acute migraine medication: Results from the American Migraine Prevalence and Prevention (AMPP) study","volume":"56","author":"Lipton","year":"2016","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0580","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2024.02.006_bib0585","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1526-4610.2007.00969.x","article-title":"Concepts and mechanisms of migraine chronification","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0590","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/0333102420941839","article-title":"Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults","volume":"40","author":"Diener","year":"2020","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0595","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0333102418758283","article-title":"Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults","volume":"38","author":"Tassorelli","year":"2018","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0600","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.2021.7939","article-title":"Acute treatments for episodic migraine in adults: A systematic review and meta-analysis","volume":"325","author":"VanderPluym","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2024.02.006_bib0605","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: A review and European consensus","volume":"123","author":"Telft-Hansen","year":"2000","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0610","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT1B\/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet."},{"issue":"Suppl 4","key":"10.1016\/j.medcli.2024.02.006_bib0615","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/head.12601","article-title":"Triptans in the acute treatment of migraine: a systematic review and network meta-analysis","volume":"55","author":"Cameron","year":"2015","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0620","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1526-4610.2005.05178.x","article-title":"Sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"45","author":"Smith","year":"2005","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0625","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0333102421989232","article-title":"Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study","volume":"41","author":"Ashina","year":"2021","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0630","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1111\/bph.15657","article-title":"Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments","volume":"178","author":"Zobdeh","year":"2021","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0635","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2024.02.006_bib0640","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: A randomised, phase3, double-blind, placebo-controlled trial","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2024.02.006_bib0645","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1526-4610.2007.00785.x","article-title":"Nebivolol and metoprolol for treatment migraine: An advance on beta-blocker treatment?","volume":"48","author":"Schellenberg","year":"2008","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0650","first-page":"CD003225","article-title":"Withdrawn: Propranolol for migraine prophylaxis","volume":"2","author":"Linde","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.medcli.2024.02.006_bib0655","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: A randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2024.02.006_bib0660","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: Results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0665","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.medcli.2024.02.006_bib0670","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.medcli.2024.02.006_bib0675","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1526-4610.2010.01800.x","article-title":"Amitriptyline in the prophylactic treatment of migraine and chronic daily headache","volume":"51","author":"Couch","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.medcli.2024.02.006_bib0680","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1526-4610.1991.hed3106388.x","article-title":"Flunarizine in migraine: A mini-review","volume":"31","author":"Leone","year":"1991","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0685","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.medcli.2024.02.006_bib0690","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1468-2982.1997.1702103.x","article-title":"Divalproex sodium in migraine prophylaxis: A dose-controlled study","volume":"17","author":"Klapper","year":"1997","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0695","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1345\/aph.1M312","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines","volume":"44","author":"Gales","year":"2010","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.medcli.2024.02.006_bib0700","first-page":"129","article-title":"Zonisamida en el tratamiento preventivo de la migra\u00f1a refractaria","volume":"50","author":"Pascual-G\u00f3mez","year":"2010","journal-title":"Rev Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0705","doi-asserted-by":"crossref","first-page":"107151","DOI":"10.1016\/j.clineuro.2022.107151","article-title":"Venlafaxine can reduce the migraine attacks as well as amitriptyline: A noninferiority randomized trial","volume":"214","author":"Hedayat","year":"2022","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.medcli.2024.02.006_bib0710","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1526-4610.2004.04198.x","article-title":"Preventing disturbing migraine aura with lamotrigine: An open study","volume":"44","author":"Pascual","year":"2004","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0715","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of action of onabotulinumtoxina in chronic migraine: A narrative review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache."},{"key":"10.1016\/j.medcli.2024.02.006_bib0720","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0725","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0730","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache J Head Face Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open."},{"key":"10.1016\/j.medcli.2024.02.006_bib0740","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11916-017-0618-8","article-title":"Neuropeptides as a marker for chronic headache","volume":"21","author":"Riesco","year":"2017","journal-title":"Curr Pain Headache Rep."},{"key":"10.1016\/j.medcli.2024.02.006_bib0745","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nrl.2019.03.013","article-title":"Calcitonin gene-related peptide in migraine: From pathophysiology to treatment","volume":"37","author":"Santos-Lasaosa","year":"2022","journal-title":"Neurologia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0750","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine","volume":"156","author":"Cernuda-Moroll\u00f3n","year":"2015","journal-title":"Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0755","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s10194-022-01431-x","article-title":"European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention \u2014 2022 update","volume":"23","author":"Sacco","year":"2022","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0760","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/01616412.2021.1940672","article-title":"Network meta-analysis on efficacy and safety of different anti-CGRP monoclonal antibody regimens for prophylaxis and treatment of episodic migraine","volume":"43","author":"Shi","year":"2021","journal-title":"Neurol Res."},{"key":"10.1016\/j.medcli.2024.02.006_bib0765","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s13311-021-01128-0","article-title":"Comparative effectiveness and tolerability of the pharmacology of monoclonal antibodies targeting the calcitonin gene-related peptide and its receptor for the prevention of chronic migraine: A network meta-analysis of randomized controlled trials","volume":"18","author":"Yang","year":"2021","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.medcli.2024.02.006_bib0770","doi-asserted-by":"crossref","first-page":"649143","DOI":"10.3389\/fphar.2021.649143","article-title":"Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine: A systematic review and network meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0775","doi-asserted-by":"crossref","first-page":"106893","DOI":"10.1016\/j.clineuro.2021.106893","article-title":"Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: A systematic review and network meta-analysis","volume":"209","author":"Soni","year":"2021","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.medcli.2024.02.006_bib0780","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s10194-021-01267-x","article-title":"MAB-MIG: Registry of the Spanish neurological society of erenumab for migraine prevention","volume":"22","author":"Belv\u00eds","year":"2021","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0785","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s10194-021-01247-1","article-title":"Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: A multicenter prospective cohort study (the GARLIT study)","volume":"22","author":"Vernieri","year":"2021","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0790","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s10194-021-01358-9","article-title":"Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States","volume":"22","author":"McAllister","year":"2021","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0795","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/cells12010143","article-title":"Monoclonal antibodies against calcitonin gene-related peptide for migraine prophylaxis: A systematic review of real-world data","volume":"12","author":"Pavelic","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.medcli.2024.02.006_bib0800","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AJP.0000000000001136","article-title":"Comparative efficacy and safety of five anti-calcitonin gene-related peptide agents for migraine prevention: A network meta-analysis","volume":"39","author":"Sun","year":"2023","journal-title":"Clin J Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0805","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/03331024211048765","article-title":"Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study","volume":"42","author":"Overeem","year":"2022","journal-title":"Cephalalgia."},{"key":"10.1016\/j.medcli.2024.02.006_bib0810","first-page":"87","article-title":"Fracaso de un anticuerpo monoclonal anti-CGRP en el tratamiento de la migra\u00f1a. \u00bfTiene sentido probar otro?","volume":"75","author":"L\u00f3pez-Moreno","year":"2022","journal-title":"Rev Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0815","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s13311-023-01394-0","article-title":"Long-term effect of switching from an anti-CGRP receptor to an anti-CGRP ligand antibody in treatment-refractory chronic migraine: A prospective real-world analysis","volume":"20","author":"Lambru","year":"2023","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.medcli.2024.02.006_bib0820","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/pmt-2020-0075","article-title":"Eptinezumab for the preventive treatment of migraine","volume":"11","author":"Villar-Mart\u00ednez","year":"2021","journal-title":"Pain Manag."},{"key":"10.1016\/j.medcli.2024.02.006_bib0825","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/1440-1681.13700","article-title":"Efficacy and safety of eptinezumab as preventive treatment for episodic\/chronic migraine: A systematic review and meta-analysis","volume":"49","author":"Siahaan","year":"2022","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0830","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","article-title":"Oral rimegepant for preventive treatment of migraine: A phase 2\/3, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Croop","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2024.02.006_bib0835","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the preventive treatment of migraine","volume":"385","author":"Ailani","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2024.02.006_bib0840","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s10194-022-01391-2","article-title":"The efficacy and safety of atogepant for the prophylactic treatment of migraine: Evidence from randomized controlled trials","volume":"23","author":"Tao","year":"2022","journal-title":"J Headache Pain."},{"key":"10.1016\/j.medcli.2024.02.006_bib0845","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/jcm11061656","article-title":"New generation gepants: Migraine acute and preventive medications","volume":"11","author":"Moreno-Ajona","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.medcli.2024.02.006_bib0850","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/WCO.0000000000000935","article-title":"Targets for migraine treatment: Beyond calcitonin gene-related peptide","volume":"34","author":"Moreno-Ajona","year":"2021","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2024.02.006_bib0855","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nrl.2022.08.004","article-title":"Inequity of access to new migraine treatments","volume":"38","author":"Irimia","year":"2023","journal-title":"Neurologia (Engl Ed)."},{"key":"10.1016\/j.medcli.2024.02.006_bib0860","first-page":"47","article-title":"Nueva era terap\u00e9utica para el ataque de migra\u00f1a con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes","volume":"78","author":"M\u00ednguez-Olaondo","year":"2024","journal-title":"Rev Neurol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T12:55:51Z","timestamp":1723812951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0025775324001374"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.02.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Documento de consenso de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), Sociedad Espa\u00f1ola de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atenci\u00f3n Primaria (SEMERGEN) y Asociaci\u00f3n Espa\u00f1ola de Migra\u00f1a y Cefalea (AEMICE) sobre el tratamiento de la migra\u00f1a","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}